SynCore Biotechnology Competitors and Similar CompaniesClear all
SynCore Biotechnology's competitors and similar companies include RenovoRx, Genentech, Livzon Pharmaceutical Group and Alembic Pharmaceuticals.
 SynCore Biotechnology SynCoreBio (杏國新藥股份有限公司) is a biopharmaceutical company engaged in the research and development of drugs with a focus on oncology, ophthalmology, dermatology, and infectious diseases. |  RenovoRx RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | |
Founding Date | Founding Date 2008 | Founding Date 2012 | Founding Date 1976 | Founding Date 1985 | Founding Date 2010 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations TW HQ | Locations Los Altos, US HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN |
Employees | Employees 40 | Employees 7 | Employees 18,077 | Employees 9,067 | Employees 14,858 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 24.8 m | Valuation ($) N/A | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) NT$23.3m (FY, 2024) | Revenue (est.) $1.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) ₹73.4b (FY, 2026) |
Cost of goods | Cost of goods NT$10.5m (FY, 2024) | Cost of goods $327k (FY, 2025) | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods ₹19.8b (FY, 2026) |
Gross profit | Gross profit NT$12.9m (FY, 2024) | Gross profit $796k (FY, 2025) | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit ₹54.1b (FY, 2026) |
Net income | Net income (NT$54.3m) (FY, 2024) | Net income ($11.2m) (FY, 2025) | Net income N/A | Net income ¥2.4b (FY, 2025) | Net income ₹6.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
RenovoRx
HQ
Los Altos, US
Employees
7
RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company